Trials show lenacapavir can all but eliminate the risk of HIV infection. Yet in the countries where it was tested, most people can't afford it.
Source: [Business Insider](https://www.businessinsider.com/gilead-faces-price-debate-over-miracle-hiv-drug-lenacapavir-2026-7)